Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT01467323

Femme et Homme

Extrait

This trial is conducted in Europe. The aim of this trial is to evaluate the efficacy and safety of biphasic insulin aspart 30 in subjects with type 1 or type 2 diabetes.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 1 ,Diabetes Mellitus, Type 2


Liens